TABLE OF CONTENTS
| PART I: COUNCIL REPORTS | |
| PAGE | |
Foreword | [1] |
Official Rules of the Council on Pharmacy and Chemistry | [3] |
The Council on Pharmacy and Chemistry, Present and Future | [12] |
“Accepted by the Council on Pharmacy and Chemistry” | [19] |
Helping the Council | [20] |
Delays in Passing on Products | [20] |
Cooperation of the Pharmaceutical Houses | [21] |
Budwell’s Emulsion of Cod-Liver Oil, Nos. 1 and 2 | [22] |
Rheumalgine | [23] |
Gray’s Glycerine Tonic | [24] |
Tongaline and Ponca Compound | [26] |
Alfatone | [28] |
Uricsol | [30] |
Jubol | [31] |
Urodonal | [32] |
Formamint | [33] |
Hydragogin | [41] |
Filudine | [41] |
Lactopeptine and Elixir Lactopeptine | [43] |
Iodum-Miller and Iod-Izd-Oil (Miller’s) | [49] |
Elixir Iodo-Bromide of Calcium Comp. “Without Mercury” and “With Mercury” | [52] |
Lecithin Preparations Omitted from N. N. R. | [53] |
Proprietary Names for Liquid Petrolatum | [55] |
Seng | [55] |
Frosst’s Blaud Capsules | [56] |
Tyree’s Elixir of Buchu and Hyoscyamus Compound | [57] |
Hydroleine | [58] |
Curative Vaccine, Bruschettini | [58] |
Stearn’s Wine | [59] |
Protonuclein and Protonuclein Beta | [59] |
Hydropsin | [61] |
Digitalysatum | [63] |
So-Called Secretin Preparations | [64] |
Has Secretin a Therapeutic Value? | [65] |
Radio-Rem | [79] |
Olio-Phlogosis | [79] |
The Hypophosphite Fallacy | [80] |
Pulvoids Calcylates | [85] |
Sulfuryl Monal | [86] |
Mark White Goiter Serum and Mark White Iodinized Oil | [87] |
Kora-Konia | [92] |
The Therapeutic Value of the Glycerophosphates | [93] |
Hydras | [96] |
Bromin-Iodin Compound | [97] |
Ammonium Hypophosphite Omitted from N. N. R. | [98] |
Alphozone Omitted from N. N. R. | [99] |
Calcium Glycerophosphate and Sodium Glycerophosphate Omitted from N. N. R. | [99] |
Gardner’s Syrup of Ammonium Hypophosphite Omitted from N. N. R. | [100] |
Gluten Products Made by the Kellogg Food Company | [100] |
Iodo-Mangan Omitted from N. N. R. | [106] |
Liquid Albolene | [106] |
Naphey’s Medicated Uterine Wafers | [107] |
Nujol | [108] |
Pulvoids Natrium Compound | [108] |
Saloform | [110] |
Secretogen | [110] |
Iron Citrate Green | [115] |
Aspirin | [116] |
Pil. Cascara Compound-Robins | [117] |
Casta-Flora | [118] |
Firwein | [119] |
Firolyptol Plain and Firolyptol with Kreosote | [120] |
Biniodol | [121] |
| Comparative Symptoms Resulting from the Use of Several Oily Suspensions of | |
Red Mercuric Iodid (Mercury Biniodid) | [123] |
Corpora Lutea (Soluble Extract), Parke, Davis & Co. | [128] |
Wheeler’s Tissue Phosphates | [129] |
The Claimed Galactagogue Effects of Nutrolactis and Goat’s Rue Not Substantiated | [131] |
The Alleged Galactagogue Action of Galega and Nutrolactis | [131] |
The Russell Emulsion and the Russell Prepared Green Bone | [134] |
Brom-I-Phos | [136] |
Creosote-Delson and Creofos | [137] |
Triner’s American Elixir of Bitter Wine | [139] |
Trimethol | [140] |
Ferrivine, Intramine and Collosol Iodine | [144] |
Eskay’s Neuro Phosphates | [146] |
K-Y Lubricating Jelly | [147] |
Ziratol | [148] |
Gonosan | [150] |
Alcresta Ipecac | [153] |
Iodeol and Iodagol | [154] |
Capsules Bismuth Resorcinol Compound Not Admitted to N. N. R. | [157] |
Dixon’s Tubercle Bacilli Extract and Dixon’s Suspension of Dead Tubercle Bacilli | [158] |
Formosol | [158] |
Iodolene, a Solution of Iodin in Liquid Petrolatum, Inadmissible to N. N. R. | [159] |
Kalak Water | [160] |
Minson’s Soluble Iodin “Kelpidine” Not Admitted to N. N. R. | [161] |
Nutone | [162] |
Tri-Arsenole, L. O. Compound No. 1 and L. O. Compound No. 2 | [163] |
Unctol | [166] |
V-E-M (Schoonmaker Laboratories, Inc.) | [166] |
Hemo-Therapin | [168] |
Venosal | [169] |
Secretin-Beveridge and the U. S. Patent Law | [170] |
The Question of the Stability of Secretin | [171] |
Need for Patent Law Revision | [177] |
Surgodine | [180] |
Medeol Suppositories | [181] |
Guaiodine | [183] |
Several “Mixed” Vaccines Not Admitted to N. N. R. | [184] |
Ophthalmol-Lindemann | [189] |
Silvol Ineligible for N.N.R | [189] |
Katharmon | [191] |
Iodinized Emulsion (Scott) and Creosotonic (Scott) | [192] |
Campetrodin and Campetrodin No. 2 | [193] |
Carminzym | [194] |
Phillips’ Phospho-Muriate of Quinine Comp | [197] |
B. Iodine and B. Oleum Iodine | [198] |
B. Iodine Products | [199] |
| Antithyroid Preparations (Antithyroidin-Moebius and Thyreoidectin) Omitted | |
from N. N. R. | [202] |
| Cephaelin and Syrup Cephaelin-Lilly Omitted from N. N. R. and Syrup Emetic-Lilly | |
Not Accepted | [203] |
Colalin Omitted from N. N. R. | [203] |
Foral | [204] |
Granular Effervescent Bromide and Acetanilid Compound-Mulford | [206] |
Holadin and Bile Salt Mixtures | [207] |
Liquor Santaiva, S. & D., Omitted from N. N. R. | [211] |
| Maltzyme, Maltzyme with Cascara Sagrada, Maltzyme with Cod Liver Oil, Maltzyme | |
Ferrated and Maltzyme with Yerba Santa Omitted from N. N. R. | [211] |
Methaform Omitted from N. N. R. | [212] |
| Pineal Gland, Red Bone-Marrow and Thymus Gland and Their Preparations | |
Omitted from N. N. R. | [213] |
Piperazine and Lycetol Omitted from N. N. R. | [214] |
Stanolind Liquid Paraffin Omitted from N. N. R. | [214] |
Westerfield’s Digitalis Tablets | [215] |
Xeroform-Heyden and Bismuth Tribromphenate-Merck Omitted from N. N. R. | [216] |
Cream of Mustard Refused Recognition | [218] |
“Pluriglandular” Mixtures | [218] |
Cerelene Not Admitted to N. N. R. | [219] |
Collosol Cocaine Not Admitted to N. N. R. | [221] |
Cuprase Not Admitted to N. N. R. | [222] |
Collosol Preparations | [223] |
Pulvoids Calcylates Compound | [226] |
Proteogens of the Wm. S. Merrell Company | [227] |
“Arsenoven S. S.” and “Arseno-Meth-Hyd” | [231] |
Hormotone and Hormotone Without Post-Pituitary | [234] |
Formaldehyde Lozenges | [235] |
Lavoris | [237] |
Medinal | [239] |
Omission of Cotarnin Salts (Stypticin and Styptol) from N. N. R. | [240] |
Micajah’s Wafers and Micajah’s Suppositories | [241] |
Alkalithia | [242] |
Arhovin Omitted from N. N. R. | [243] |
Chloron, Chlorax and Number “3” | [244] |
Elarson Omitted from N. N. R. | [248] |
Iodiphos | [249] |
Mervenol and Armervenol Not Admitted to N. N. R. | [249] |
| Normal Phenol Serum (Cano) and Methyl-Phenol Serum (Cano) Not Accepted | |
for N. N. R. | [251] |
Soamin Omitted from N. N. R. | [253] |
Some Mixed Vaccines Not Admitted to N. N. R. | [254] |
Somnoform | [255] |
Tablets Formothalates | [256] |
Triple Arsenates with Nuclein | [256] |
“Anti-Pneumococcic Oil” and the Use of Camphor in Pneumonia | [257] |
Dial “Ciba” | [259] |
Apothesine | [260] |
Eumictine | [262] |
Platt’s Chlorides | [263] |
| Anti-Tuberculous Lymph Compound (Sweeny) and Anti-Syphilitic Compound | |
(Sweeny) | [266] |
Syrup Leptinol (Formerly Syrup Balsamea) | [268] |
Formitol Tablets, II | [271] |
Sukro-Serum and Aphlegmatol | [273] |
Supsalvs Not Admitted to N. N. R. | [274] |
| Hypodermic Solution No. 13, Iron, Arsenic and Phosphorus Compound Not | |
Accepted for N. N. R. | [275] |
Parathesin Not Admitted to N. N. R. | [276] |
Chlorlyptus | [277] |
Aquazone (Oxygen Water) | [290] |
Coagulen-Ciba Omitted from N. N. R. | [290] |
Ferric Cacodylate Omitted from New and Non-Official Remedies | [292] |
Libradol | [293] |
Helmitol Omitted from N. N. R. | [295] |
Spirocide Not Admitted to N. N. R. | [296] |
Digifolin-Ciba Not Admitted to N. N. R. | [298] |
Some of Loesser’s Intravenous Solutions | [299] |
“National Iodine Solution” Not Admitted to N. N. R. | [300] |
Mon-Arsone Not Admitted to N. N. R. | [302] |
Oxyl-Iodide Not Admitted to N. N. R. | [304] |
Quassia Compound Tablets | [306] |
Toxicide | [307] |
Pil. Mixed Treatment (Chichester) | [310] |
Atophan Omitted from N. N. R. | [313] |
Urotropin Omitted from N. N. R. | [316] |
Styptysate Not Admitted to N. N. R. | [318] |
Lipoidal Substances (Horovitz) Not Admitted to N. N. R. | [320] |
Yeast Preparations and Vitamin B Concentrates | [321] |
| PART II: CONTRIBUTIONS FROM THE A. M. A. CHEMICAL LABORATORY | |
The Chemical Laboratory of the American Medical Association | [322] |
The Work of the American Medical Association Chemical Laboratory | [322] |
Lead in “Akoz” | [328] |
Sodium Acetate in Warming Bottles | [329] |
Anti-Syphilitic Compound (Sweeny) | [330] |
“Ambrine” and Paraffin Films | [330] |
The Stability of Iodine Ointments | [337] |
Iodolene and the Solubility of Iodin in Liquid Petrolatum | [344] |
American-Made Synthetic Drugs—I | [344] |
Standardization of Commercial Bismuth Tribromphenate | [348] |
Standardization of Procain and Examination of the Market Supply | [355] |
Deterioration of Sodium Hypochlorite Solutions | [358] |
Syphilodol | [359] |
Cerelene | [362] |
Dr. De Sanctis’ Rheumatic and Gout Pills | [363] |
Iodex and Liquid Iodex | [365] |
| PART III: CONTRIBUTIONS FROM THE JOURNAL: PROPRIETARY PRODUCTS | |
Iodin in Liquid Petrolatum | [367] |
American-Made Synthetic Drugs—II | [369] |
Nostrums in Retrospect | [379] |
Bell-Ans (Pa-Pay-Ans Bell) | [380] |
Anasarcin and Anedemin | [383] |
Pepto-Mangan | [387] |
Cactina Pillets | [391] |
Ammonol and Phenalgin | [393] |
Fellows’ Syrup, and Other Preparations of the Hypophosphites | [395] |
Shotgun Nostrums | [398] |
Tyree’s Antiseptic and Aseptinol | [401] |
Neurosine and the Original Package Evil | [404] |
Anasarcin Advertising | [407] |
Antimeristem-Schmidt | [408] |
Antiphlogistine | [409] |
“Auto-Hemic Serum” | [409] |
“Autolysin” Advertising | [413] |
“Basic Cancer Research” and “Cosmopolitan Cancer Research Society” | [414] |
Seleni-Bascca | [416] |
Bell-Ans (Papayans, Bell) | [418] |
Campho-Phenique | [418] |
“Cinchophen”: Formerly “Atophan” | [419] |
“Collosols”: An Uncritical English Endorsement | [420] |
Cotton Process Ether | [421] |
Dionol | [422] |
The Eli Products of Eli H. Dunn | [424] |
Glover’s Cancer Serum | [425] |
Glyco-Thymoline and Poliomyelitis | [427] |
Glykeron: Cold Storage Testimonials | [428] |
Gray’s Glycerine Tonic: “Whose Bread I Eat His Song I Sing” | [429] |
Hagee’s Cordial of Cod Liver Oil | [429] |
Hypno-Bromic Compound | [430] |
Intravenous Compound (Loffler) | [430] |
Intravenous Specialties | [435] |
Iodex | [436] |
The William F. Koch Cancer Remedy | [437] |
The Lucas Laboratories’ Products | [440] |
“Phylacogens” | [441] |
Pineoleum Advertising Methods | [442] |
“Proteal Therapy” and Henry Smith Williams | [443] |
Proteogens | [445] |
Pulvane | [450] |
Sal Hepatica | [451] |
Salicon | [453] |
So-Called Secretin Preparations | [454] |
Succus Cineraria Maritima | [455] |
Tekarkin | [458] |
Tyree’s Antiseptic Powder Again | [462] |
Wheeler’s Tissue Phosphates | [463] |
Briefer Paragraphs | [465] |
| PART IV: CONTRIBUTIONS FROM THE JOURNAL: MISCELLANY | |
Albert Abrams, A.M., M.D., LL.D., F.R.M.S. | [472] |
Acetylsalicylic Acid, Not Aspirin | [480] |
The Allied Medical Associations of America | [486] |
“Arsenicals” | [491] |
Beer and Cancer Cures | [494] |
Biologic Therapeutics and Its Commercial Domination | [496] |
Capell’s Uroluetic Test | [497] |
Chemotherapy and Tumors | [499] |
The Direct Sales Company | [510] |
Discoveries and Discoverers | [511] |
“Drug Reform” | [513] |
Drug Therapy: The Fallibility of Textbooks | [515] |
Thomas Webster Edgar | [515] |
Glycerophosphates | [520] |
Influenza Vaccine | [520] |
Intravenous Therapy | [522] |
Iodin Fumes | [523] |
Italian Physico-Chemical Company | [524] |
What is Liquid Petrolatum? | [526] |
The Lowenthal Postgraduate Course | [527] |
Medical Society of the United States | [531] |
The National Formulary—A Review of the Fourth Edition | [535] |
Nonspecific Protein Therapy | [536] |
Willard Ealon Ogden | [538] |
“Patents” | [542] |
Pharmaceutical Barnums | [545] |
The Pharmacopeia | [546] |
Physician’s Stock in Prescription Products | [548] |
Pituitary Gland Preparations | [549] |
Proprietorship in Medicine | [550] |
Philip Rahtjen and His Discoveries | [553] |
Sodium Cacodylate in Syphilis | [555] |
Tablets: Dependability of Dosage | [556] |
Therapeutic Evidence: Its Crucial Test | [557] |
“Vaccines in Toxic Conditions” | [560] |
Vitamins: Their Distribution | [561] |
The William A. Webster Co. and the Direct Pharmaceutical Co. | [564] |
Yeast | [566] |
Briefer Paragraphs | [570] |
THE PROPAGANDA FOR REFORM IN PROPRIETARY MEDICINES